Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.23.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
REVENUES $ 8,831 $ 8,545
COST OF REVENUES 4,721 4,575
GROSS PROFIT 4,110 3,970
OPERATING EXPENSES:    
Research and development expenses, net 2,766 2,443
Sales and marketing expenses, net 3,282 2,204
General and administrative expenses, net 4,163 1,183
TOTAL OPERATING EXPENSES 10,211 5,830
OPERATING LOSS (6,101) (1,860)
Interest expenses (830) (690)
Other financial expenses, net (4,051) (2,701)
NET COMPREHENSIVE LOSS FOR THE YEAR $ (10,982) $ (5,251)
Net loss per share attributable to common shareholders – basic and diluted (in Dollars per share) $ (0.95) $ (2.56)
Weighted average number of common stock used in computing net loss per share – basic and diluted (in Shares) 11,621,238 2,048,788